← Scroll for more →
Jushi Holdings Inc. (JUSH)
Medicinal Chemicals & Botanical Products
Latest Price
--
Market Cap
--
TTM P/E
--
Earnings Yield
--
TTM Div Yield
--
P/B Ratio
--
Earnings yield is trailing 12-month earnings divided by price.
Financials
financial statements →| Quarter ending | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Last 4 quarters |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76.82M | $69.87M | $66.42M | $65.38M | $67.77M | $65.46M | $64.59M | $61.61M | $65.86M | $63.85M | $65.05M | $65.68M | $68.34M | $66.43M | $71.30M | $70.47M | $276.54M |
| Gross margin | 28.6% | 42.9% | 46.0% | 43.6% | 40.2% | 49.4% | 50.4% | 45.4% | 38.6% | 40.4% | 44.5% | 46.7% | 41.9% | 45.0% | 44.2% | 45.9% | 44.2% |
| Operating margin | -181.2% | -3.6% | 5.1% | 4.3% | -9.6% | 6.3% | 13.0% | 0.3% | -2.8% | -2.9% | 5.5% | 3.6% | 1.1% | 2.4% | 1.0% | 5.0% | 2.4% |
| Net income | -$139.94M | -$12.44M | -$14.04M | -$20.62M | -$18.00M | -$18.36M | -$1.94M | -$16.02M | -$12.47M | -$17.02M | -$12.33M | -$23.69M | -$15.56M | -$19.85M | -$7.33M | -$12.52M | -$55.25M |
| Net margin | -182.2% | -17.8% | -21.1% | -31.5% | -26.6% | -28.0% | -3.0% | -26.0% | -18.9% | -26.6% | -19.0% | -36.1% | -22.8% | -29.9% | -10.3% | -17.8% | -20.0% |
| Operating cash flow | $4.78M | -$3.57M | -$6.71M | $2.46M | $4.51M | $6.49M | $5.55M | $2.37M | $7.15M | $7.53M | -$1.94M | $6.08M | $6.05M | $8.61M | $793,000 | $3.54M | $18.99M |
| Free cash flow | -$2.87M | -$8.11M | -$8.31M | $217,000 | $2.15M | $5.42M | $4.86M | $1.60M | $4.98M | $3.51M | -$6.05M | $1.21M | $2.96M | $5.58M | -$3.10M | $637,000 | $6.08M |
Chart: revenue per quarter, Dec 2022 to Sep 2026. Hover over or tap a row to chart it.
Quarters ending Dec 2024 to Sep 2026, oldest first.
Revenue ($M)
Last 4 quarters $276.54M
$80M$0
65.963.865.065.768.366.471.370.5
Gross margin (%)
Last 4 quarters 44.2%
50%0%
38.640.444.546.741.945.044.245.9
Operating margin (%)
Last 4 quarters 2.4%
6%0%-3%
-2.8-2.95.53.61.12.41.05.0
Net income ($M)
Last 4 quarters -$55.25M
$0-$25M
-12-17-12-24-16-20-7-13
Net margin (%)
Last 4 quarters -20.0%
0%-40%
-19-27-19-36-23-30-10-18
Operating cash flow ($M)
Last 4 quarters $18.99M
$10M$0
7.27.5-1.96.16.18.60.83.5
Free cash flow ($M)
Last 4 quarters $6.08M
$6M$0-$8M
5.03.5-6.11.23.05.6-3.10.6
Capital Structure
balance sheet →- Shares Outstanding
- 199.71M
- Total Debt
- $226.84M
- Long-term Debt
- $194.47M
- Long-term Debt / Capital
- --
- Cash
- $28.73M
- Current Assets
- $74.13M
- Current Liabilities
- $93.59M
Debt as of 2026-09-30; current position as of 2026-09-30.
Recent Material Events
all events →- Jushi Holdings Inc. filed an 8-K to furnish an updated investor presentation dated November 10, 2026. The presentation reports trailing twelve-month (LTM) Q3 2026 revenue of approximately $277 million and adjusted EBITDA of roughly $52 million. It outlines operational metrics across eight markets, including 42 operating stores and 323,000 square feet of cultivation capacity. Key strategic priorities include preparing for Virginia's anticipated adult-use cannabis sales launch on July 1, 2027, optimizing operations in Pennsylvania and Ohio, and expanding retail footprints in secondary markets like Illinois and Massachusetts. The company also notes the completion of a $160 million non-dilutive debt refinancing in March 2026 and recent DEA registrations for medical operations under the new Schedule III framework. Jushi Holdings Inc. operates as a vertically integrated cannabis platform, cultivating, processing, and dispensing medical and adult-use marijuana across multiple U.S. states.
- Jushi Holdings Inc. reported third-quarter 2026 financial results with total revenue increasing 7% year-over-year to $70.5 million. Gross profit was $32.3 million, and adjusted EBITDA rose to $13.6 million from $12.8 million in the prior year period. The company posted a net loss of $12.5 million, narrowing significantly from the $23.7 million loss reported in Q3 2025. Wholesale revenue surged 40% to $9.7 million, while retail revenue grew 3.5% to $60.8 million. Jushi Holdings Inc. is a vertically integrated multi-state cannabis operator.
Insider Transactions
all insider transactions →| Name | Title | Transaction | Shares | Price | Date |
|---|---|---|---|---|---|
| Cacioppo James | Chief Executive Officer | Open Market Purchase | 20 | $0.51 | 2026-09-18 |
| Arsenault Denis J. | -- | Open Market Purchase | 15.1K | $0.62 | 2026-09-08 |
| Arsenault Denis J. | -- | Open Market Purchase | 118.0K | $0.59 | 2026-09-03 |
| Cacioppo James | Chief Executive Officer | Open Market Purchase | 248.0K | $0.52 | 2026-09-01 |
| Barack Louis Jon | President | Open Market Purchase | 15.0K | $0.52 | 2026-08-31 |